Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People with the chronic inflammatory lung disease are about two times more likely to have a heart attack.
Additionally, researchers found that those with an unsupressed viral load had higher risk than those people with undetectable HIV.
HIV-positive people who experience a heart attack and require hospitalization are more likely to die, compared with HIV-negative people.
Most HIV-positive people who should be taking aspirin to prevent a heart attack or stroke are not doing so.
There is no association between the use of ViiV Healthcare’s abacavir—found in Ziagen, Epzicom and Trizivir—and heart attack risk.
Daily aspirin could help reduce risk of complications associated with blood clots, immune activation and inflammation in people with HIV.
Elevated blood pressure is associated with a greater risk of a heart attack among people with HIV, compared with HIV-negative controls.
People taking abacavir (found in Ziagen, Epzicom and Trizivir) had no greater risk of having a heart attack than people not taking abacavir, a...
There is no association between the use of ViiV Healthcare’s nucleoside analogue abacavir—found in Ziagen, Epzicom and Trizivir—and heart....
The risk of developing various forms of cardiovascular disease in people living with HIV decreases with time upon stopping cigarette smoking,...
Use of the nucleoside reverse transcriptase inhibitor (NRTI) abacavir is not associated with an increased risk of a heart attack or stroke.
New data from the SMART trial indicate that abacavir is associated with an increased risk of cardiovascular disease.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.